Unichem Lab receives Rs270 crore as first tranche of payment in Optimus stake sale

26 Sep 2022 , 09:16 AM

Unichem Laboratories Ltd has announced to the exchanges that the sale of 19.97% equity shares in Optimus Drugs Private Limited (“Optimus”) to Sekhmet Pharmaventures Private Limited has been completed on September 22, 2022, and it has received payment towards completion of sale of first tranche.

For the first tranche the company has received Rs270,98,99,010 and further for the second tranche, the price to be determined as per the said share purchase agreement after satisfaction of necessary conditions precedent, the company said in a regulatory filing.

Moreover, incorporated on December 2, 2003, Optimus is engaged in the business of researching, developing, manufacturing, marketing, and distribution of active pharmaceutical ingredients and intermediates.

On Monday morning trade, Unichem Laboratories Ltd is currently trading at Rs387.95 per share down by Rs2.65 or 0.68% from its previous closing of Rs390.60 per share on the BSE.

For feedback and suggestions, write to us at [e-mail]